Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06456554 · ClinicalTrials.gov registry record · NA

Acellular Dermal Matrix Investigation in Breast Reconstruction

A NA study of Breast Reconstruction, sponsored by RTI Surgical.

Recruiting
Registry status
NA
Development phase
467
Enrollment target
10
Study locations

NCT06456554 is a NA study of Breast Reconstruction that is actively recruiting participants, run by RTI Surgical. The registered enrollment target is 467 participants, above the 368-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (27% higher). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06456554, a NA study of Breast Reconstruction, is actively recruiting participants, sponsored by RTI Surgical.

RECRUITING
Registry status
NA
Development phase
467 participants
Enrollment target
10
Study locations

Study Summary

Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.

Conditions Studied

Interventions

  • DEVICE Acellular Dermal Matrix (Cortiva Tissue Matrix)

Study Locations (10)

Missouri

  • Washington University - St Louis
  • Mercy Hospital - St Louis

New York

  • NYU Langone Health - New York
  • New York Presbyterian Hospital/Columbia University Irving Medical Center - New York

Arkansas

  • University of Arkansas - Little Rock

California

  • City of Hope National Medical Center - Duarte

Colorado

  • University of Colorado - Aurora

Ohio

  • Cleveland Clinic - Cleveland

Oklahoma

  • Mercy Hospital - Oklahoma City

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 467 participants
Start Date 2024-11-22
Est. Completion 2027-12
Phase NA

Sponsor

RTI Surgical

12 total trials

What the Registry Record Tells You About NCT06456554

The ClinicalTrials.gov registry entry for NCT06456554 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 467 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 368-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (27% higher). The listed sponsor is RTI Surgical, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Acellular Dermal Matrix (Cortiva Tissue Matrix) is the first listed.

NCT06456554 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Missouri, New York, Arkansas.

Frequently Asked Questions

What is clinical trial NCT06456554 about?

NCT06456554 is a clinical study titled "Acellular Dermal Matrix Investigation in Breast Reconstruction". Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.

What is the current status of trial NCT06456554?

This trial is currently recruiting. It is a NA study. The enrollment target is 467 participants. The study started on 2024-11-22. Estimated completion is 2027-12.

What conditions does trial NCT06456554 study?

This clinical trial studies the following conditions: Breast Reconstruction.

What interventions are being tested in trial NCT06456554?

The interventions under investigation include: Acellular Dermal Matrix (Cortiva Tissue Matrix) (DEVICE).

Who is sponsoring clinical trial NCT06456554?

This trial is sponsored by RTI Surgical, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06456554 being conducted?

This trial has 10 study locations across Arkansas, California, Colorado, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Reconstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.